Serum visfatin in patients with type two diabetic retinopathy
BACKGROUND: The primary cause of blindness in diabetics is diabetic retinopathy (DR), the most common microvascular complication of diabetes, and visual impairment. Visfatin is an adipocytokine that aids in insulin activity during gestational diabetes and pregnancy.AIM: This study aimed to estimate...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2024-11-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/13165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849729791903662080 |
|---|---|
| author | I. N. Salman N. U. G. Mohammed S. E. Atta B. A. Abed R. Salim |
| author_facet | I. N. Salman N. U. G. Mohammed S. E. Atta B. A. Abed R. Salim |
| author_sort | I. N. Salman |
| collection | DOAJ |
| description | BACKGROUND: The primary cause of blindness in diabetics is diabetic retinopathy (DR), the most common microvascular complication of diabetes, and visual impairment. Visfatin is an adipocytokine that aids in insulin activity during gestational diabetes and pregnancy.AIM: This study aimed to estimate serum visfatin levels in DR, proliferative (PDR), non-proliferative (NPDR), and healthy subjects (HS).MATERIALS AND METHODS: A 120-patient case-control study with a history of T2DM for more than 5 years as well as 30 healthy subjects enrolled in the study. Patients group divided into three sub-groups, DM, PDR, and NPDR. Visfatin levels were measured using a commercially available enzyme-linked immunosorbent assay kit. Triglyceride (TG), serum cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) levels and glycated haemoglobin (HbA1c) were assessed.RESULTS: The PDR patients and patients with poor glycemic control showed significantly increased visfatin levels compared with the HS group and T2DM patients without DR. The TC, TG, and DR group’s LDL-C levels were noticeably higher and significantly greater in PDR than in the group of HS.CONCLUSION: Visfatin levels have been linked to both the severity and existence of DR. and more in patients with poor glycemic control. Elevated lipids were associated with DR risk. |
| format | Article |
| id | doaj-art-2fd4a3a477fa42078f4981dfff291bd2 |
| institution | DOAJ |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-2fd4a3a477fa42078f4981dfff291bd22025-08-20T03:09:04ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782024-11-0127548048610.14341/DM1316511121Serum visfatin in patients with type two diabetic retinopathyI. N. Salman0N. U. G. Mohammed1S. E. Atta2B. A. Abed3R. Salim4Mustansiriyah University/National Diabetes CenterUniversity of Baghdad/College of Science for Women/department of ChemistryMustansiriyah University/National Diabetes CenterMustansiriyah University/National Diabetes CenterUniversity of Baghdad/College of Science for Women/department of ChemistryBACKGROUND: The primary cause of blindness in diabetics is diabetic retinopathy (DR), the most common microvascular complication of diabetes, and visual impairment. Visfatin is an adipocytokine that aids in insulin activity during gestational diabetes and pregnancy.AIM: This study aimed to estimate serum visfatin levels in DR, proliferative (PDR), non-proliferative (NPDR), and healthy subjects (HS).MATERIALS AND METHODS: A 120-patient case-control study with a history of T2DM for more than 5 years as well as 30 healthy subjects enrolled in the study. Patients group divided into three sub-groups, DM, PDR, and NPDR. Visfatin levels were measured using a commercially available enzyme-linked immunosorbent assay kit. Triglyceride (TG), serum cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) levels and glycated haemoglobin (HbA1c) were assessed.RESULTS: The PDR patients and patients with poor glycemic control showed significantly increased visfatin levels compared with the HS group and T2DM patients without DR. The TC, TG, and DR group’s LDL-C levels were noticeably higher and significantly greater in PDR than in the group of HS.CONCLUSION: Visfatin levels have been linked to both the severity and existence of DR. and more in patients with poor glycemic control. Elevated lipids were associated with DR risk.https://www.dia-endojournals.ru/jour/article/view/13165diabetic retinopathylipid profiletype 2 diabetes mellitusglycemic controlvisfatin |
| spellingShingle | I. N. Salman N. U. G. Mohammed S. E. Atta B. A. Abed R. Salim Serum visfatin in patients with type two diabetic retinopathy Сахарный диабет diabetic retinopathy lipid profile type 2 diabetes mellitus glycemic control visfatin |
| title | Serum visfatin in patients with type two diabetic retinopathy |
| title_full | Serum visfatin in patients with type two diabetic retinopathy |
| title_fullStr | Serum visfatin in patients with type two diabetic retinopathy |
| title_full_unstemmed | Serum visfatin in patients with type two diabetic retinopathy |
| title_short | Serum visfatin in patients with type two diabetic retinopathy |
| title_sort | serum visfatin in patients with type two diabetic retinopathy |
| topic | diabetic retinopathy lipid profile type 2 diabetes mellitus glycemic control visfatin |
| url | https://www.dia-endojournals.ru/jour/article/view/13165 |
| work_keys_str_mv | AT insalman serumvisfatininpatientswithtypetwodiabeticretinopathy AT nugmohammed serumvisfatininpatientswithtypetwodiabeticretinopathy AT seatta serumvisfatininpatientswithtypetwodiabeticretinopathy AT baabed serumvisfatininpatientswithtypetwodiabeticretinopathy AT rsalim serumvisfatininpatientswithtypetwodiabeticretinopathy |